Rapid nucleic acid extraction method based on diatom frustules
By using diatom shells to adsorb and enrich nucleic acids in nucleic acid extraction, the problems of slow extraction speed and high cost in the prior art are solved, and fast and efficient nucleic acid extraction is achieved, suitable for clinical diagnosis and on-site detection, and reduce impurities inhibition.
Patent Information
- Application Number
- CN202211511331.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-29
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-11-29
AI Technical Summary
The existing nucleic acid extraction methods have problems such as slow extraction speed, cumbersome steps, high cost and impurities inhibit downstream amplification reactions, especially in large-scale epidemic screening and nucleic acid testing.
Using a rapid nucleic acid extraction method based on diatom shells, by mixing the diatom shell with biological samples, using anion-cation-anion salt bridge to adsorb and enrich nucleic acids on the surface of diatom shells, simplifying the extraction process, reducing costs, and applicable Nucleic acid extraction from different biological samples.
It achieves simple operation, high extraction efficiency, low cost, fast extraction speed, high quality of nucleic acid products, and is suitable for clinical diagnosis and on-site rapid detection, reducing impurity inhibition in subsequent amplification detection.
Smart Images

Figure HDA0003969187280000011 
Figure HDA0003969187280000012 
Figure HDA0003969187280000021
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of nucleic acid extraction, and particularly relates to a rapid nucleic acid extraction method based on diatom frustules. Background Art
[0002] Nucleic acid testing has become the main means of detecting pathogenic microorganisms due to its excellent sensitivity and specificity. Among them, nucleic acid extraction is an important component and necessary process of nucleic acid testing. Since nucleic acids in biological samples are usually contained in cells or virus particles and are tightly bound to various proteins, and various organic impurities in biological samples, such as heme and mucin, will inhibit downstream nucleic acid detection reactions, insufficient nucleic acid extraction will result in too low a target nucleic acid content in the product, resulting in poor repeatability and sensitivity of the test results. Therefore, obtaining high-quality nucleic acids is extremely important for nucleic acid testing.
[0003] Currently, the nucleic acid extraction methods that have been made public are mainly divided into two types: liquid phase extraction and solid phase extraction. The principle of liquid phase extraction is to separate compounds based on their relative solubility (DOI: 10.1021 / acs.analchem.1c04460). Among them, organic reagent extraction is the most classic liquid phase extraction method, but it uses a variety of highly toxic organic reagents such as chloroform and phenol during the extraction process, and the extraction cycle is long, so it has been gradually eliminated. There are many studies in the field of liquid phase extraction of nucleic acids. S. Fister et al. (DOI: 10.1016 / j.seppur.2015.03.035) tested 16 different ionic liquids to compare the recovery rate of DNA extraction; Clark et al. (DOI: 10.1021 / ac504260t) first demonstrated the use of hydrophobic ionic liquids to extract nucleic acids. Hydrophobic magnetic ionic liquids can be used for magnetically assisted dispersed liquid-liquid microextraction, which can shorten the extraction time and improve the extraction efficiency; Marengo et al. (DOI: 10.1186 / s13007-019-0408-x) further used this method to achieve the extraction of Arabidopsis thaliana genomic DNA, and optimized the volume and extraction time of the magnetic ionic liquid.
[0004] Compared with liquid phase extraction, solid phase extraction of nucleic acids has the advantages of efficient phase separation, low contamination risk and less sample requirements (DOI: 10.1016 / j.trac.2019.03.008). The most commonly used solid phase extraction methods are magnetic bead method and centrifugal column method. Chinese invention patent CN113667664A discloses a nucleic acid extraction method based on nanomagnetic beads. The extracted nucleic acid has high quality and can meet the basic requirements of molecular biological experiments. However, this nucleic acid extraction method still has some problems that cannot be ignored. Because it includes elution and washing steps, the magnetic bead extraction takes a long time and the steps are complicated. In addition, the cost of magnetic bead materials is high, which is not conducive to large-scale screening of epidemics. In the study of centrifugal column method for nucleic acid extraction, silica material is the main base material for preparing centrifugal columns, so it is used as a solid phase matrix for nucleic acid extraction. Pearlman et al. (DOI: 10.1021 / acsami.9b21564) developed a simple and low-cost nucleic acid extraction method based on silica material. This method uses magnetic beads, pipettes, steel wool and external magnets to achieve high-gradient magnetic separation, which is suitable for samples of different volumes; Ana B. Dávila-Ibáñez et al. (DOI: 10.1039 / c3nr34358h) found that the silica and Fe 3 O 4 Or it can be combined with a polymer adsorbent to effectively adsorb DNA, but the specific surface area of this microsphere is small, and its DNA adsorption capacity is very limited, resulting in a low DNA separation yield; Chinese invention patent CN114450419A discloses a method for nucleic acid extraction using a silica solid support. This method introduces a variety of metal ions into the extraction buffer, which will cause it to inhibit the downstream amplification reaction.
[0005] Diatoms are photosynthetic unicellular algae and a natural source of nanostructured silica. These microorganisms produce highly ordered porous cell walls in their membranes, called diatom shells (DOI: 10.3390 / app10196811). Diatom shells have a huge specific surface area due to their unique mesoporous structure and have shown excellent performance in many aspects. Jeehee Lee et al. (DOI: 10.1021 / acsnano.0c00621) found that diatom shells have superhydrophilicity and superhemophilicity due to their nanoporous structure, and developed a new type of hemostatic material based on this; Ellegaard et al. (DOI: 10.1007 / s10811-016-0893-5) found that diatom shells can be used to reduce ultraviolet radiation; GW Lim et al. (DOI: 10.1007 / s10811-014-0356-9) found that diatom shells have a better adsorption effect on proteins. Currently, there are few reports on the adsorption of nucleic acids by diatom frustules, and there is no research on the use of diatom frustules for nucleic acid extraction.
[0006] Chinese invention patents (CN113755484A, CN113930132A, CN114988456A, CN114107282A, CN111298765A) disclose methods for extracting nucleic acids using diatomaceous earth as a solid phase matrix. However, the diatomaceous earth used in the above methods needs to be chemically modified. The nucleic acids in the sample are adsorbed and enriched by chemical groups added to the surface of the diatomaceous earth. The steps are cumbersome and the cost is increased. In addition, the diatomaceous earth used in these methods can only be used for the adsorption and enrichment of nucleic acids, and cannot complete the lysis of biological samples and the release of nucleic acids. The biological samples need to be pretreated through additional steps such as thermal lysis or chemical reagent lysis, and the process is complicated.
[0007] Therefore, how to quickly and efficiently extract nucleic acids from samples, increase the concentration of nucleic acids, and reduce impurities that inhibit downstream amplification and detection reactions is the key to nucleic acid extraction technology. In order to simplify the extraction process, further improve the efficiency of nucleic acid extraction, and reduce the cost of nucleic acid extraction, it is urgent to develop a new nucleic acid extraction technology that can be applied to nucleic acid detection in various fields. Summary of the invention
[0008] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a rapid nucleic acid extraction method based on diatom shells, which is simple to operate, low in cost, high in extraction efficiency, fast in extraction speed and high in nucleic acid product quality.
[0009] The rapid nucleic acid extraction method based on diatom frustules described in the present invention is to mix the diatom frustules with the biological sample. The diatom frustules can lyse the biological sample to release the nucleic acid, and adsorb and enrich the nucleic acid on the surface of the diatom frustules through the action of the "anion-cation-anion" salt bridge, and collect the diatom frustule precipitate to complete the nucleic acid extraction.
[0010] The diatom shell is derived from marine unicellular diatoms, which are marine unicellular organisms containing siliceous shells, preferably Thalassiosira wissensis ( Thalassiosira weissflogii )、Cryptic Cyclotella( Cyclotella cryptica ), Thalassiosira pseudonana ( Thalassiosira sp. ), Navicula ( Navicula sp. ), Oval algae ( Cocconeiopsis orthoneoides )、Cross-grass algae( Pleurosigma indicum )、Circular sieve algae( Coscinodiscus sp. )
[0011] Preferably, the diatom shell purification method refers to a new method for extracting pure diatom shells from marine unicellular diatoms disclosed in Chinese invention patent CN112978738A. The purification process is simple and easy, and the obtained diatom shells are complete in morphology and low in organic matter. The specific steps of the diatom shell purification method are as follows: collect 1L of algae liquid by centrifugation or filtration, add 25mL of concentrated sulfuric acid to the diatom mud, mix thoroughly and heat in a 60°C water bath for 45min, and leave at room temperature for 24h; continue to add an equal volume of concentrated nitric acid, heat at 60°C until clear, leave at room temperature for 24h, collect the treated algae cells through sieve silk filtration, wash 5 times with distilled water, wash 5 times with anhydrous ethanol, and dry at 60°C to obtain pure diatom shells.
[0012] The biological samples are oropharyngeal swab extract and serum.
[0013] The sources of the nucleic acid are prokaryotic cells, eukaryotic cells and virus particles.
[0014] Preferably, 1-20 μg of diatom frustules and 20-1000 μL of biological sample, preferably the volume of the biological sample is 50-200 μL.
[0015] Preferably, a method for preparing an oropharyngeal swab extract sample is as follows: an oropharyngeal swab is collected from a volunteer in accordance with the requirements of the "Training Program for Coronavirus Nucleic Acid Sampling" issued by the National Health Commission. After collection, the swab is immersed in a centrifuge tube containing 500 μL of normal saline, placed on a vortex oscillator and oscillated for 30 seconds, and the pharyngeal swab is discarded to obtain the oropharyngeal swab extract sample.
[0016] Preferably, the method for preparing serum is as follows: the collected blood sample is placed in a collection tube without an anticoagulant, and naturally coagulated at room temperature for 30-60 minutes. After the blood coagulates, the blood clot is gently cut along the collection tube, and the blood is placed at 4°C overnight. After equilibrium, the collection tube is placed in a centrifuge and centrifuged at 4°C, with a speed of 3000 rpm for 15 minutes. After the centrifugation, the supernatant is collected to obtain the serum sample.
[0017] Preferably, after the diatom frustules are mixed with the biological sample, an inorganic salt solution is added to promote the enrichment of nucleic acids in the diatom frustules, wherein the inorganic salt includes magnesium chloride or sodium chloride, and the final concentrations of magnesium ions and sodium ions in the extraction system are 0.1-100 mM and 0.1-1000 mM, respectively.
[0018] The diatom frustule precipitate can be used for nucleic acid amplification detection. The detection can be performed after the diatom frustule precipitate is mixed with an amplification buffer. The preferred nucleic acid amplification detection method is polymerase chain reaction (PCR).
[0019] In actual operation, the nucleic acid extraction process of the present invention involves two steps: (1) mixing diatom frustules with biological samples, lysing the biological samples, and adsorbing and enriching nucleic acids on the diatom frustules, and (2) collecting diatom frustule precipitates to complete nucleic acid extraction;
[0020] Wherein, in step (1), in order to fully mix the diatom shells with the biological sample, lyse the sample and fully contact the nucleic acid, manual inversion mixing and vortex oscillator oscillation mixing can be used, preferably oscillator mixing, and the oscillation time is 1-60 sec. In order to promote the adsorption of nucleic acids by diatom shells, sodium ions or magnesium ions can be introduced to promote the adsorption and enrichment of nucleic acids on the surface of diatom shells;
[0021] In step (2), when collecting the diatom frustule precipitate, the diatom frustule precipitate can be left to settle for 1-5 minutes or centrifuged at 1000-4000 rpm for 1-60 seconds, and the supernatant is carefully aspirated and discarded to collect the diatom frustule precipitate for amplification detection.
[0022] Preferably, the biological sample and diatom shells can be directly mixed in an amplification tube to extract nucleic acids. After discarding the supernatant, the amplification buffer system can be directly added to the amplification tube for downstream amplification, thereby achieving single-tube extraction and detection of nucleic acids, which can be used for integrated "from sample to answer" rapid nucleic acid detection.
[0023] Compared with the prior art, the present invention has the following beneficial effects:
[0024] 1. The operation steps are simple. No additional processing of biological samples is required to release nucleic acids, no conventional washing and elution steps are required, no large instruments are required, and the equipment and instrument requirements are low. Only a small vortex oscillator and a micro centrifuge are required to complete the nucleic acid extraction.
[0025] 2. High extraction efficiency, fast extraction speed, and high quality of nucleic acid products. The entire extraction process can be completed in just 5-10 minutes, and has an extraction efficiency comparable to commercially available kits, which are commonly used nucleic acid extraction kits: magnetic bead-based viral DNA / RNA extraction kit (DP438, Tiangen Biochemical Technology Co., Ltd.) and blood / cell / tissue genomic DNA extraction kit (DP304, Tiangen Biochemical Technology Co., Ltd.).
[0026] 3. The extraction system is simple and low in cost. The present invention does not require lysing agents such as guanidine salts and sodium dodecyl sulfate (SDS) and washing reagents such as ethanol and isopropanol, which reduces costs while avoiding the inhibitory effect of the above reagents on subsequent amplification detection.
[0027] 4. Wide applicability. The present invention is applicable to the extraction of nucleic acids from different biological samples, provides a new nucleic acid extraction method for the field of clinical diagnosis technology, and has broad application prospects in the application of rapid on-site nucleic acid detection.
[0028] 5. Promote the progress of basic research. The present invention provides a theoretical basis and practical reference for the research and development of new natural biomaterials for nucleic acid extraction. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 , scanning electron microscope images of diatom shells;
[0030] Figure 2 , Escherichia coli O157:H7 specific gene fluorescence amplification curve of serum sample in Example 1;
[0031] Figure 3 , Escherichia coli O157:H7 specific gene fluorescence amplification curve of serum sample in Example 2;
[0032] Figure 4 , Staphylococcus aureus in serum samples of Example 3 nuc Gene fluorescence amplification curve;
[0033] Figure 5 , Fluorescence amplification curve of the hepatitis B virus S protein gene of the serum sample of Example 4;
[0034] Figure 6 , Fluorescence amplification curve of the human internal reference gene RNase P gene of the oropharyngeal swab extract sample in Example 5;
[0035] Figure 7 , Fluorescence amplification curves of the hepatitis B virus S protein gene using various nucleic acid extraction methods for serum samples. DETAILED DESCRIPTION
[0036] The present invention will be further described below in conjunction with the embodiments.
[0037] It should be noted that, unless otherwise specified, all raw materials used in the examples are commercially available.
[0038] In the examples, the target nucleic acid was detected by fluorescent real-time PCR method, and the total volume of the PCR amplification reaction buffer system was 20 μL, and the components were shown in Table 1. The process of fluorescent real-time PCR was as follows: the amplification mixture was subjected to rapid thermal cycling using the CFX Connect™ Real-Time PCR System (purchased from Bio-Rad, USA), including initial denaturation at 95°C for 3 min and 40 rapid cycles of 95°C for 15 sec and 58°C for 10 sec, and the fluorescent signal was collected every other cycle, and a fluorescence curve graph of the change over time was plotted.
[0039] Table 1 PCR amplification reaction buffer system composition
[0040] name Final concentration dNTPs 0.2 mM 10× Amplification Buffer 1× 10 × Evagreen 1× Taq DNA polymerase 0.5 U Deionized water Add to 20 μL
[0041] Example 1: Nucleic acid extraction and Escherichia coli O157:H7 detection in serum samples
[0042] Based on the conserved sequence of Escherichia coli O157:H7, specific primers were designed using NCBI Blast (https: / / blast.ncbi.nlm.nih.gov / ) software and NUPACK software (www.nupack.org / ).
[0043] Primer sequences:
[0044] Primer F: 5'-CCATGTGCAATATGCAACTAC-3'(CP064383.1) (SEQ ID NO:1)
[0045] Primer R: 5'-CTTCATCTCCTTCCGATATACC-3'(CP064383.1) (SEQ ID NO:2)
[0046] Take 100 μL of the bacterial solution of Escherichia coli O157:H7 in the logarithmic phase in a centrifuge tube and dilute it 10 times in a gradient at a ratio of 1:9 for later use. Mix 990 μL of the serum sample with 10 μL of the diluted Escherichia coli O157:H7 bacterial solution to prepare a serum sample simulating Escherichia coli infection. Take 20 μL of the serum sample and mix it with 1 μg of Ovalbuminae ( Cocconeiopsis orthoneoides ) and add 10 μL of 3.6% (w / v) sodium chloride solution and 10 μL of 100 mM magnesium chloride solution to make the final concentrations of sodium ions and magnesium ions 153.85 mM and 25 mM, respectively. Oscillate on a small vortex oscillator for 15 seconds to allow the diatom shells and nucleic acids to fully contact. Place the centrifuge tube in a microcentrifuge and centrifuge at 3000 rpm for 60 seconds. Carefully remove the supernatant, mix the diatom shell precipitate with the amplification buffer, and add the above primers for nucleic acid amplification reaction detection. The final concentrations of the two primers are 4×10 -7 M, amplification results are as follows Figure 2 The negative control group (NTC) was a simulated sample prepared by adding an equal amount of blank culture medium instead of Escherichia coli O157:H7 bacterial solution into serum.
[0047] from Figure 2 It can be seen that the specific gene of Escherichia coli O157:H7 was detected in the serum sample nucleic acid extracted by the method of the present invention.
[0048] Example 2: Nucleic acid extraction and Escherichia coli O157:H7 detection in serum samples
[0049] Based on the highly conserved sequence of Escherichia coli O157:H7, specific primers were designed using NCBI Blast (https: / / blast.ncbi.nlm.nih.gov / ) software and NUPACK software (www.nupack.org / ).
[0050] Primer sequences:
[0051] Primer F: 5'-CCATGTGCAATATGCAACTAC-3'(CP064383.1) (SEQ ID NO:1)
[0052] Primer R: 5'-CTTCATCTCCTTCCGATATACC-3'(CP064383.1) (SEQ ID NO:2)
[0053] Take 100 μL of the bacterial solution of Escherichia coli O157:H7 in the logarithmic phase in a centrifuge tube and dilute it 10 times in a gradient at a ratio of 1:9 for later use. Mix 990 μL of the serum sample with 10 μL of the diluted Escherichia coli O157:H7 bacterial solution to prepare a serum sample simulating Escherichia coli infection. Take 1000 μL of the serum sample and mix it with 20 μg of Thalassiosira wissenschaft ( Thalassiosira weissflogii )、Cryptic Cyclotella( Cyclotella cryptica ) and Navicula ( Navicula sp. ) and add 200 μL of 3.6% (w / v) sodium chloride solution to make the final sodium ion concentration 102.56 mM. Invert the centrifuge tube 10 times by hand, then place the centrifuge tube on a centrifuge tube rack and let it stand for 1 min to allow the diatom shells to settle to the bottom of the centrifuge tube. Carefully remove the supernatant, mix the diatom shell precipitate with the amplification buffer, and add the above primers for nucleic acid amplification reaction detection. The final concentration of the two primers is 4×10 -7 M, amplification results are as follows Figure 3 The negative control group (NTC) was a simulated sample prepared by mixing an equal amount of blank culture medium instead of Escherichia coli O157:H7 bacterial solution into serum.
[0054] from Figure 3 It can be seen that the specific gene of Escherichia coli O157:H7 was detected in the serum sample nucleic acid extracted by the method of the present invention. The results show that the nucleic acid extraction method of the present invention is simple to operate, does not require the use of oscillation and centrifugation equipment, and can also extract nucleic acids quickly and efficiently. It can be used to extract nucleic acids and perform on-site instant detection under conditions where there is a lack of instruments and equipment.
[0055] Example 3: Nucleic acid extraction from serum samples and Staphylococcus aureus nuc Genetic testing
[0056] Based on Staphylococcus aureus nuc The conserved sequences of genes were identified and specific primers were designed using NCBI Blast (https: / / blast.ncbi.nlm.nih.gov / ) and NUPACK (www.nupack.org / ).
[0057] Primer sequences:
[0058] Primer F: 5'-GTCGAGTTTGACAAAGGTC-3'(DQ399678.1) (SEQ ID NO:3)
[0059] Primer R: 5'-TTAGCCAAGCCTTGACG-3'(DQ399678.1) (SEQ ID NO:4)
[0060] Take 100 μL of the bacterial solution of logarithmic phase Staphylococcus aureus in a centrifuge tube and dilute it 10 times in a gradient at a ratio of 1:9 for later use. Mix 990 μL of serum sample with 10 μL of diluted Escherichia coli O157:H7 bacterial solution to prepare a serum sample simulating E. coli infection. Take 100 μL of serum sample and mix it with 5 μg of Thalassiosira pseudonana ( Thalassiosira sp. ) and add 40 μL of 93.75 mM (w / v) magnesium chloride solution to make the final magnesium ion concentration 26.79 mM. Oscillate on a small vortex shaker for 30 seconds to allow the diatom shells and nucleic acid to fully contact. Place the centrifuge tube in a microcentrifuge and centrifuge at 2000 rpm for 30 seconds. Carefully remove the supernatant, mix the diatom shell precipitate with the amplification buffer, and add the above primers for nucleic acid amplification reaction detection. The final concentration of both primers is 4×10 -7 M, amplification results are as follows Figure 4 The negative control group (NTC) was a simulated sample prepared by adding an equal amount of blank culture medium instead of Staphylococcus aureus culture solution into serum.
[0061] from Figure 4 It can be seen that Staphylococcus aureus was detected in the serum sample nucleic acid extracted by the method of the present invention. nuc Gene.
[0062] Example 4: Nucleic acid extraction from serum samples and detection of hepatitis B virus S protein gene
[0063] Based on the S protein gene sequence of hepatitis B virus, specific primers were designed using NCBI Blast (https: / / blast.ncbi.nlm.nih.gov / ) software and NUPACK software (www.nupack.org / ).
[0064] Primer sequences:
[0065] Primer F: 5'-AGACTCGTGGTGGACTTC-3' (AB809557.1) (SEQ ID NO:5)
[0066] Primer R: 5'-GGTTGGTGAGTGATTGGAG-3' (AB809557.1) (SEQ ID NO:6)
[0067] Take 200 μL of serum sample from a hepatitis B patient or a volunteer with negative hepatitis B virus test result and mix it with 5 μg of Cynomorium sibiricum ( Coscinodiscus sp. ) and Cyclotella cryptomerica ( Cyclotella cryptica ) and add 100 μL of 100 mM (w / v) magnesium chloride solution to make the final magnesium ion concentration 33.33 mM. Oscillate on a small vortex oscillator for 10 seconds to allow the diatom shells and nucleic acid to fully contact. Place the centrifuge tube in a microcentrifuge and centrifuge at 1000 rpm for 30 seconds. Carefully remove the supernatant, mix the diatom shell precipitate with the amplification buffer, and add the above primers for nucleic acid amplification reaction detection. The final concentration of both primers is 4×10 -7 M, amplification results are as follows Figure 5 The negative control group (NTC) was the serum of volunteers with negative HBV test results.
[0068] from Figure 5 It can be seen that the S protein gene of hepatitis B virus was detected in the serum sample nucleic acid extracted by the method of the present invention.
[0069] Example 5: Nucleic acid extraction from oropharyngeal swab extract samples and detection of human internal reference gene RNase P gene
[0070] Based on the commonly used human internal reference gene RNase P gene sequence, specific primers were designed using NCBI Blast (https: / / blast.ncbi.nlm.nih.gov / ) software and NUPACK software (www.nupack.org / ).
[0071] Primer sequences:
[0072] Primer F: 5'-GGCCATCAGAAGGAGATGAAGATT-3' (NM_006413.5) (SEQ ID NO:7)
[0073] Primer R: 5'-CATTCTTTCAGCCCTCACACT-3' (NM_006413.5) (SEQ ID NO:8)
[0074] 10 μg of Algae ( Pleurosigma indicum ) on a small vortex shaker for 30 seconds. Place the centrifuge tube in a microcentrifuge and centrifuge at 3000 rpm for 20 seconds to centrifuge the diatom shells to the bottom of the centrifuge tube. Carefully remove the supernatant, mix the diatom shell precipitate with the amplification buffer, and add the above primers to perform nucleic acid amplification reaction detection. The final concentration of the two primers is 4×10 -7 M, amplification results are as follows Figure 6 The negative control group (NTC) was the extract of a blank throat swab whose throat was not swabbed.
[0075] from Figure 6 It can be seen that the human internal reference gene RNaseP gene was detected in the serum sample nucleic acid extracted by the method of the present invention.
[0076] Example 6: Comparison of various nucleic acid extraction methods
[0077] Based on the S protein gene sequence of hepatitis B virus, specific primers were designed using NCBI Blast (https: / / blast.ncbi.nlm.nih.gov / ) software and NUPACK software (www.nupack.org / ).
[0078] Primer sequences:
[0079] Primer F: 5'-AGACTCGTGGTGGACTTC-3' (AB809557.1) (SEQ ID NO:5)
[0080] Primer R: 5'-GGTTGGTGAGTGATTGGAG-3' (AB809557.1) (SEQ ID NO:6)
[0081] Take 200 μL of serum sample from a hepatitis B patient or a volunteer with negative hepatitis B virus test result and mix it with 20 μg of Cynomorium sibiricum ( Coscinodiscus sp. ) and Cyclotella cryptomerica ( Cyclotella cryptica ) and add 80 μL of 100 mM (w / v) magnesium chloride solution to make the final magnesium ion concentration 28.57 mM. Vortex for 15 seconds to allow the diatom shells and nucleic acid to fully contact. Place the centrifuge tube in a microcentrifuge and centrifuge at 1000 rpm for 15 seconds. Carefully remove the supernatant, mix the diatom shell precipitate with the amplification buffer, and add the above primers for nucleic acid amplification reaction detection. The final concentration of the two primers is 4×10 -7 M.
[0082] According to the product instructions, the same serum samples were used for nucleic acid extraction using a magnetic bead-based viral DNA / RNA extraction kit (DP438, Tiangen Biochemical Technology Co., Ltd.), a blood / cell / tissue genomic DNA extraction kit (DP304, Tiangen Biochemical Technology Co., Ltd.), and a sample nucleic acid releaser (JM103, Qingdao Jianma Gene Technology Co., Ltd.). The nucleic acid extraction products were used as targets for PCR amplification detection, and the number of cycles required to reach the fluorescence threshold (C t The nucleic acid extraction efficiency of each method was judged by the value of Figure 7 The negative control group (NTC) was the serum of volunteers with negative HBV test results.
[0083] from Figure 7 It can be seen that the PCR amplification reaction using the nucleic acid extracted by the method of the present invention as a template has the lowest C t This indicates that this method is superior to commercially available kits.
Claims
1. A rapid nucleic acid extraction method based on diatom frustules, Features: The diatom frustules are mixed with biological samples. The diatom frustules can lyse the biological samples to release nucleic acids, and adsorb and enrich nucleic acids. The diatom frustule precipitates are collected to complete the nucleic acid extraction. Biological samples were oropharyngeal swab extracts or serum samples; After the diatom frustules are mixed with the biological sample, an inorganic salt solution is added to promote the enrichment of nucleic acids in the diatom frustules; The inorganic salt includes magnesium chloride or sodium chloride, and the final concentrations of magnesium ions and sodium ions in the extraction system are 0.1-100 mM and 0.1-1000 mM, respectively; Diatom frustules are marine single-celled diatoms; Marine unicellular diatoms are marine single-celled organisms with siliceous shells; The marine unicellular organisms containing siliceous shells are one or more of Thalassiosira wissensis, Cyclotella cryptorchida, Thalassiosira pseudomicronaria, Navicula, Ovadella, Tillandsia, and Cyclostridium; The specific steps of the diatom shell purification method are as follows: collect 1L of algae liquid by centrifugation or filtration, add 25mL of concentrated sulfuric acid to the diatom mud, mix thoroughly and heat in a 60℃ water bath for 45min, and leave at room temperature for 24h; continue to add an equal volume of concentrated nitric acid, heat at 60℃ until clear, leave at room temperature for 24h, collect the treated algae cells by sieve silk filtration, wash with distilled water 5 times, wash with anhydrous ethanol 5 times, and dry at 60℃ to obtain pure diatom shells; The method for preparing an oropharyngeal swab extract sample is as follows: collecting an oropharyngeal swab, immersing the swab in a centrifuge tube containing 500 μL of physiological saline after the collection is completed, placing the swab on a vortex shaker for 30 seconds, and discarding the pharyngeal swab to obtain the oropharyngeal swab extract sample; The method for preparing serum is as follows: the collected blood sample is placed in a collection tube without an anticoagulant, and naturally coagulated for 30-60 minutes at room temperature. After the blood coagulates, the blood clot is gently cut along the collection tube, and placed at 4°C overnight. After it is balanced, the collection tube is placed in a centrifuge and centrifuged at 4°C, with a speed of 3000 rpm for 15 minutes. After the centrifugation is completed, the supernatant is collected to obtain the serum sample.
2. The rapid nucleic acid extraction method based on diatom frustules according to claim 1, Features: The sources of nucleic acids are prokaryotic cells, eukaryotic cells and viral particles.
3. The rapid nucleic acid extraction method based on diatom frustules according to claim 1, Features: The amount of diatom frustules used is 1-20 μg, and the amount of biological samples used is 20-1000 μL.
Citation Information
Patent Citations
Application of purified and modified diatomite in adsorption and inactivation of viruses and product
CN111298765A
Method for extracting pure diatom shells from marine single-cell diatom
CN112978738A
Kit for extracting nucleic acid by using nano magnetic beads and extraction method
CN113667664A
Nucleic acid extraction method and application
CN113755484A
Gallic acid modified diatomite modified epoxy resin paint and preparation method thereof
CN113930132A
